Quarterly Report (10-q)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2016

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to .

Commission File Number: 0-21810

GENTHERM INCORPORATED

(Exact name of registrant as specified in its charter)


Michigan		95-4318554
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)
21680 Haggerty Road, Northville, MI		48167
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (248) 504-0500

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer”, “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer	☒		Accelerated filer	☐
Non-accelerated filer	☐		Smaller reporting company	☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

At October 27, 2016, there were 36,510,338 issued and outstanding shares of Common Stock of the registrant.

GENTHERM INCORPORATED

TABLE OF CONTENTS

Cover
Table of Contents
Part I. Financial Information			3
	Item 1.	Financial Statements (Unaudited)	3
		Consolidated Condensed Balance Sheets	3
		Consolidated Condensed Statements of Income	4
		Consolidated Condensed Statements of Comprehensive Income	5
		Consolidated Condensed Statements of Cash Flows	6
		Consolidated Condensed Statement of Changes in Shareholders’ Equity	7
		Notes to Unaudited Consolidated Condensed Financial Statements	8
	Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	23
	Item 3.	Quantitative and Qualitative Disclosures About Market Risk	28
	Item 4.	Controls and Procedures	30
Part II. Other Information			31
	Item 1.	Legal Proceedings	31
	Item 1A.	Risk Factors	31
	Item 6.	Exhibits	31
Signatures			32

PART I. FINANCIAL INFORMATION

ITEM 1.

FINANCIAL STATEMENTS

GENTHERM INCORPORATED

CONSOLIDATED CONDENSED BALANCE SHEETS

(In thousands, except share data)

(Unaudited)

	September 30, 2016			December 31, 2015
ASSETS
Current Assets:
Cash and cash equivalents	$	132,813		$	144,479
Accounts receivable, less allowance of $1,698 and $955, respectively		178,965			142,610
Inventory:
Raw materials		64,185			50,371
Work in process		12,909			4,150
Finished goods		30,110			29,662
Inventory, net		107,204			84,183
Deferred income tax assets		7,335			6,716
Prepaid expenses and other assets		38,679			42,620
Total current assets		464,996			420,608
Property and equipment, net		167,336			119,157
Goodwill		52,935			27,765
Other intangible assets, net		62,947			48,461
Deferred financing costs		849			310
Deferred income tax assets		21,882			22,094
Other non-current assets		38,608			8,403
Total assets	$	809,553		$	646,798
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current Liabilities:
Accounts payable	$	88,814		$	77,115
Accrued liabilities		111,355			60,823
Current maturities of long-term debt		899			4,909
Deferred tax liabilities		229			211
Derivative financial instruments		806			725
Total current liabilities		202,103			143,783
Pension benefit obligation		6,933			6,545
Other liabilities		3,107			5,026
Long-term debt, less current maturities		140,673			92,832
Deferred income tax liabilities		11,623			14,321
Total liabilities		364,439			262,507
Shareholders’ equity:
Common Stock:
No par value; 55,000,000 shares authorized, 36,495,338 and 36,321,775 issued and outstanding at September 30, 2016 and December 31, 2015, respectively		260,598			256,919
Paid-in capital		1,460			(1,282	)
Accumulated other comprehensive loss		(47,830	)		(51,670	)
Accumulated earnings		230,886			180,324
Total shareholders’ equity		445,114			384,291
Total liabilities and shareholders’ equity	$	809,553		$	646,798

See accompanying notes to the consolidated condensed financial statements.

GENTHERM INCORPORATED

CONSOLIDATED CONDENSED STATEMENTS OF INCOME

(In thousands, except per share data)

(Unaudited)

	Three Months Ended September 30,						Nine Months Ended September 30,
	2016			2015			2016			2015
Product revenues	$	232,625		$	223,818		$	681,059		$	644,168
Cost of sales		155,931			148,892			464,628			436,967
Gross margin		76,694			74,926			216,431			207,201
Operating expenses:
Net research and development expenses		19,745			14,934			54,552			44,459
Acquisition transaction expenses		22			—			693			—
Selling, general and administrative expenses		29,512			22,543			81,533			71,546
Total operating expenses		49,279			37,477			136,778			116,005
Operating income		27,415			37,449			79,653			91,196
Interest expense		(660	)		(759	)		(2,287	)		(1,867	)	)
Revaluation of derivatives		—			(134	)		—			(1,151	)
Foreign currency (loss) gain		(873	)		420			88			748
Other income		359			487			754			944
Earnings before income tax		26,241			37,463			78,208			89,870
Income tax expense		6,018			9,798			27,646			22,891
Net income	$	20,223		$	27,665		$	50,562		$	66,979
Basic earnings per share	$	0.55		$	0.77		$	1.39		$	1.86
Diluted earnings per share	$	0.55		$	0.76		$	1.38		$	1.84
Weighted average number of shares – basic		36,477			36,110			36,426			35,951
Weighted average number of shares – diluted		36,595			36,482			36,558			36,390

See accompanying notes to the consolidated condensed financial statements.

GENTHERM INCORPORATED

CONSOLIDATED CONDENSED STATEMENTS OF COMPREHENSIVE INCOME

(In thousands)

(Unaudited)

	Three Months Ended September 30,						Nine Months Ended September 30,
	2016			2015			2016			2015
Net income	$	20,223		$	27,665		$	50,562		$	66,979
Other comprehensive loss, gross of tax:
Foreign currency translation adjustments gain (loss)		2,230			(4,429	)		2,866			(19,312	)
Unrealized loss on foreign currency derivative securities		(868	)		(460	)		(624	)		(1,237	)
Unrealized gain (loss) on commodity derivative securities		139			(373	)		544			(421	)
Other comprehensive income (loss), gross of tax	$	1,501		$	(5,262	)	$	2,786		$	(20,970	)
Other comprehensive income (loss), related tax effect:
Foreign currency translation adjustments gain (loss)		(13	)		51			1,087			764
Unrealized loss on foreign currency derivative securities		233			125			168			335
Unrealized gain (loss) on commodity derivative securities		(51	)		155			(201	)		155
Other comprehensive income (loss), related tax effect	$	169		$	331		$	1,054		$	1,254
Other comprehensive income (loss), net of tax	$	1,670		$	(4,931	)	$	3,840		$	(19,716	)
Comprehensive income	$	21,893		$	22,734		$	54,402		$	47,263

See accompanying notes to the consolidated condensed financial statements.

GENTHERM INCORPORATED

CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

	Nine Months Ended September 30,
	2016			2015
Operating Activities:
Net income	$	50,562		$	66,979
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation and amortization		27,724			23,123
Deferred income tax benefit		(1,933	)		(4,262	)
Stock compensation		6,856			4,687
Defined benefit plan expense		151			284
Provision of doubtful accounts		385			309
Gain on revaluation of financial derivatives		—			(951	)
Loss on write-off or intangible assets		—			358
Loss (gain) on sale of property and equipment		291			(41	)
Changes in operating assets and liabilities:
Accounts receivable		(22,835	)		(24,442	)
Inventory		(5,647	)		(3,829	)
Prepaid expenses and other assets		2,826			(1,313	)
Accounts payable		6,508			1,722
Accrued liabilities		6,123			3,712
Net cash provided by operating activities		71,011			66,336
Investing Activities:
Proceeds from the sale of property and equipment		45			226
Acquisition of subsidiary, net of cash acquired		(73,593	)		(47	)
Purchases of property and equipment		(50,742	)		(35,728	)
Net cash used in investing activities		(124,290	)		(35,549	)
Financing Activities:
Borrowing of debt		75,000			15,000
Repayments of debt		(32,368	)		(4,156	)
Excess tax (expense) benefit from equity awards		(277	)		1,220
Cash paid for financing costs		(650	)		—
Cash paid for the cancellation of restricted stock		(1,196	)		(1,475	)
Proceeds from the exercise of Common Stock options		1,038			6,468
Net cash provided by financing activities		41,547			17,057
Foreign currency effect		66			(4,372	)
Net (decrease) increase in cash and cash equivalents		(11,666	)		43,472
Cash and cash equivalents at beginning of period		144,479			85,700
Cash and cash equivalents at end of period	$	132,813		$	129,172
Supplemental disclosure of cash flow information:
Cash paid for taxes	$	18,183		$	23,870
Cash paid for interest	$	1,963		$	1,420
Supplemental disclosure of non-cash transactions:
Common Stock issued to Board of Directors and employees	$	3,507		$	2,287

See accompanying notes to the consolidated condensed financial statements.

GENTHERM INCORPORATED

CONSOLIDATED CONDENSED STATEMENT OF CHANGES IN SHAREHOLDERS’ EQUITY

(In thousands)

(Unaudited)

												Accumulated
												Other
	Common Stock						Paid-in			Accumulated		Comprehensive
	Shares			Amount			Capital			Earnings		Loss			Total
Balance at December 31, 2015		36,322		$	256,919		$	(1,282	)	$	180,324	$	(51,670	)	$	384,291
Exercise of Common Stock options for cash		67			1,368			(330	)		—		—			1,038
Tax benefit from exercises of Common Stock options		—			—			(277	)		—		—			(277	)
Cancellation of restricted stock		(28	)		(1,196	)		—			—		—			(1,196	)
Stock option compensation		—			—			3,349			—		—			3,349
Common Stock issued to Board of Directors and employees		134			3,507			—			—		—			3,507
Currency translation, net		—			—			—			—		3,953			3,953
Foreign currency hedge, net		—			—			—			—		(456	)		(456	)
Commodity hedge, net		—			—			—			—		343			343
Net income		—			—			—			50,562		—			50,562
Balance at September 30, 2016		36,495		$	260,598		$	1,460		$	230,886	$	(47,830	)	$	445,114

See accompanying notes to the consolidated condensed financial statements.

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

(Unaudited)

Note 1 – The Company and Subsequent Events

Gentherm Incorporated is a global technology and industry leader in the design, development, and manufacturing of innovative thermal management technologies and automotive cable systems. Unless the context otherwise requires, the terms “Company”, “we”, “us” and “our” used herein refer to Gentherm Incorporated and its consolidated subsidiaries. Our products provide solutions for automotive passenger comfort and convenience, battery thermal management, remote power generation, patient temperature management, and other consumer and industrial temperature control needs. Our automotive products can be found on the vehicles of nearly all major automotive manufacturers operating in North America, Europe and Asia. We operate in locations aligned with our major customers’ product strategies in order to provide locally enhanced design, integration and production capabilities and to identify future thermal technology product opportunities in both automotive and other markets. We concentrate our research on the development of new technologies that will enable new products, improve overall effectiveness of existing products and maximize customer satisfaction. We also focus on developing new design applications from our existing technologies to create new products and market opportunities for thermal comfort solutions.

North American Reorganization

On January 4, 2016 and January 5, 2016, the Company completed reorganization transactions (the “Reorganization”) related to our North American business (the “Windsor Operations”). As part of our original integration plan to eliminate redundancies associated with the 2011 acquisition of Gentherm GmbH (formally named W.E.T. Automotive Systems AG), the Windsor Operations have been consolidated into our existing European and North American facilities. As a result of the Reorganization, some of the business activities previously performed by the Windsor Operations will now be performed by other subsidiaries.

Related to the Reorganization, the Company declared an intercompany dividend, incurred and paid a related withholding tax to the Canadian Revenue Agency and recorded a tax expense of approximately $6,300, during the first quarter of 2016. Later during the quarter, a further intercompany dividend was declared and paid resulting in an additional $1,300 withholding tax being paid and expensed and the Company changed its assessment of the potential for further dividends and accrued and expensed, but did not pay, an estimated final withholding tax amount totaling $2,000. This estimate is expected to cover the amount of all future intercompany dividends needed to distribute the remaining earnings of the subsidiary to its parent in conjunction with the final liquidation of the subsidiary.

In addition to the $9,600 in combined withholding taxes, the Reorganization will require the Company to make a one-time income tax payment of approximately $32,000. The one-time income tax payment was accrued during the first quarter of 2016; however, the Company also recorded an offsetting deferred charge for approximately the same amount because the one-time income tax payment will result in tax deductions against income taxes in future periods. Therefore, the income tax payment did not have a material impact on the Company’s earnings during the first quarter of 2016 and is not expected to have a material impact in any future fiscal quarter. The income tax payment will be paid during 2017 and is included in accrued liabilities as of September 30, 2016. The deferred charge is included in other non-current assets as of September 30, 2016.

Cincinnati Sub-Zero

On April 1, 2016, we acquired all of the equity of privately-held Cincinnati Sub-Zero Products, LLC (“CSZ”) and related assets in an all-cash transaction. CSZ manufactures both high quality patient temperature management systems for the health care industry and custom testing equipment used by a wide range of industrial manufacturing companies for product testing. CSZ’s world headquarters and manufacturing operations are located in Cincinnati, Ohio. See Note 3, “Cincinnati Sub-Zero Acquisition” for additional information regarding CSZ.

Subsequent Events

We have evaluated subsequent events through the date that our consolidated condensed financial statements are issued. No events have taken place that meet the definition of a subsequent event requiring adjustments to or disclosures in this filing.

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

(Unaudited)

Note 2 – Basis of Presentation and New Accounting Pronouncements

The accompanying unaudited consolidated condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and note disclosures normally included in the audited annual consolidated financial statements prepared in accordance with generally accepted accounting principles in the United States of America have been condensed or omitted pursuant to those rules and regulations. In the opinion of management, all adjustments, consisting of normal recurring items, considered necessary for a fair presentation of our results of operations, financial position and cash flows have been included. The balance sheet as of December 31, 2015 was derived from audited annual consolidated financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America. Certain reclassifications of prior year’s amounts have been made to conform with the current year’s presentation. Operating results for the nine months ended September 30, 2016 are not necessarily indicative of the results that may be expected for the year ending December 31, 2016. These consolidated condensed financial statements should be read in conjunction with the financial statements and the notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2015.

Financial Instruments

In January, 2016, the Financial Accounting Standards Board (“FASB”) issued ASU 2016-01, “Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities” ASU 2016-01 requires equity investments not accounted for under the equity method of accounting or which result in consolidation of an investee, that have readily determinable fair values, to be measured at fair value with changes in the fair value recognized in net income. The update simplifies the impairment assessment for equity investments without readily determinable fair values by requiring assessment for impairment qualitatively, similar to the impairment assessment currently used for long-lived assets, goodwill and indefinite-lived intangible assets. The amendments in this update also change the disclosure requirements for financial instruments, including eliminating the requirement to disclose the method and significant assumptions used to estimate the fair value for financial instruments measured at amortized costs on the balance sheet.

ASU 2016-01 is effective for fiscal years and interim periods beginning after December 15, 2017 and early adoption of the amendments in this update are not permitted. ASU 2016-01 is not expected to significantly impact the Company.

Leases

In February, 2016, the FASB issued ASU 2016-02, “Leases (Topic 842).” ASU 2016-02 requires lessees to recognize on their balance sheet a liability to make lease payments and a right-of-use asset representing its right to use the underlying asset for the lease term. Payments to be made in optional periods should be included in the measurement of lease assets and liabilities if the lessee is reasonably certain it will exercise an option to extend the lease or not exercise an option to terminate the lease. While ASU 2016-02 continues to differentiate between finance or capital leases and operating leases, the principal change from current lease accounting guidance is that lease assets and liabilities arising from operating leases should be recognized on the balance sheet.

ASU 2016-02 is effective for fiscal years and interim periods beginning after December 15, 2018. Early adoption of the amendments in this update are permitted. Lessees are required to recognize and measure leases at the beginning of the earliest period presented using a modified retrospective approach which includes a number of practical expedients, including the ability to use hindsight in evaluating lessee options to extend or terminate a lease. An entity that elects to apply the practical expedients will be required to recognize a right-of-use asset and lease liability for all operating leases at each reporting date based on the present value of the remaining minimum rental payment that were tracked and disclosed under previous GAAP. We are currently in the process of determining the impact the implementation of ASU 2016-02 will have on the Company’s financial statements.

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

(Unaudited)

Note 2 – Basis of Pre sentation and New Accounting Pronouncements – Continued

Stock Compensation

In March, 2016, the FASB issued ASU 2016-09, “Compensation – Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting.” ASU 2016-09 involves several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows. Under the new standard, income tax benefits and deficiencies are to be recognized as income tax expense or benefit in the income statement and the tax effects of exercised or vested awards should be treated as discrete items in the reporting period in which they occur. An entity should also recognize excess tax benefits regardless of whether the benefit reduces taxes payable in the current period. Excess tax benefits should be classified along with other income tax cash flows as an operating activity. In regards to forfeitures, the entity may make an entity-wide accounting policy election to either estimate the number of awards that are expected to vest or account for forfeitures when they occur.

ASU 2016-09 is effective for fiscal years and interim periods beginning after December 15, 2016. Early adoption of the amendments in this update are permitted . The Company is currently evaluating the guidance to determine the Company's adoption method and the effect it will have on the Company's consolidated financial statements.

Statement of Cash Flows

In August, 2016, the FASB issued ASU 2016-15, “Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments.” ASU 2016-15 provides guidance on the classification of eight specific cash receipt and cash payment transactions in the statement of cash flows. The Company is currently evaluating the following transactions to determine the effect ASU 2016-15 will have on the Company’s Consolidated Statements of Cash Flows:

Debt extinguishment payments and debt prepayments are to be shown as cash outflows for financing activities. Presently, Gentherm classifies debt extinguishment payments within operating activities.

Payments made to settle contingent consideration liabilities not made soon after the acquisition date of a business combination should be recognized as cash outflows for financing activities up to the amount of the liability recognized at the acquisition date. Payments, or the portion of a payment, to settle contingent consideration liabilities that exceed the amount of the liability recognized at the acquisition date will be recognized as cash outflows for operating activities.

Cash receipts from the settlement of insurance claims, excluding those related to corporate-owned life insurance policies shall be classified on the basis of the related insurance coverage. For example, proceeds received to cover claims issued under product recall liability insurance would be classified as cash inflows from operating activities.

Cash receipts from the settlement of corporate-owned life insurance policies shall be classified as cash inflows from investing activities.

The other cash receipt and cash payment transactions addressed by this update are not expected to impact the Company. For public companies, ASU 2016-15 is effective for fiscal years and interim periods beginning after December 15, 2017 and must be applied retrospectively to all periods presented. Early adoption of the amendments in this update are permitted.

Revenue from Contracts with Customers

In May, 2014, the FASB issued ASU 2014-09, “Revenue from Contracts with Customers.” ASU 2014-09 was developed to enable financial statement users to better understand the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. The update’s core principal is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Companies are to use a five-step contract review model to ensure revenue gets recognized, measured and disclosed in accordance with this principle. In April, 2016, the FASB issued ASU 2016-10, “Identifying Performance Obligations and Licensing” to, amongst other things, reduce the cost and complexity it takes to identify performance obligations in a contract (step two in the five-step contract review model). As a result, entities are not required to assess whether promised goods or services are performance obligations if they are immaterial in the context of the contract.

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

(Unaudited)

Note 2 – Basis of Presentation and New Accounting Pronouncements – Continued

In June, 2015, the FASB issued ASU 2015-14, “Deferral of the Effective Date.” As a result of this update, ASU 2014-09 and ASU 2016-10 will be effective for fiscal years and interim periods beginning after December 15, 2017. The amendments in these updates will be applied either retrospectively to each prior reporting period presented or retrospectively with the cumulative effect recognized at the date of initial application. Gentherm has developed a plan to complete the five-step contract review process for all existing contracts with customers. We are currently in the process of determining the impact the implementation of ASU 2014-09 and ASU 2016-10 will have on the Company’s financial statements.

Inventory – Simplifying the Measurement of Inventory

In July, 2015, the FASB issued ASU 2015-11, “ Inventory (Topic 330) Simplifying the Measurement of Inventory.” The update requires that inventory measured using any method other than last-in, first-out (LIFO) or the retail inventory method shall be measured at the lower of cost and net realizable value.

ASU 2015-11 is effective for fiscal years and interim periods beginning after December 15, 2016. Early adoption of the amendments in this update are permitted. ASU 2015-11 is not expected to significantly impact the Company.

Balance Sheet Classification of Deferred Taxes

In November, 2015, the FASB issued ASU 2015-17, “ Income Taxes (Topic 740) Balance Sheet Classification of Deferred Taxes.” ASU 2015-17 no longer requires an entity to separate deferred income tax liabilities and assets into current and noncurrent amounts on the balance sheet. Instead, for each tax paying component and within each tax jurisdiction all deferred tax liabilities and assets, as well as related valuation allowance, shall be offset and presented as a single noncurrent amount. Entities will continue to not offset deferred tax liabilities and assets attributable to different tax-paying components of the entity or to different tax jurisdictions.

ASU 2015-17 is effective for fiscal years and interim periods beginning after December 15, 2016, though earlier application is permitted. The update can be applied either prospectively to all deferred tax liabilities and assets or retrospectively to all periods presented. We anticipate adoption of ASU 2015-17 will impact our presentation of deferred tax liabilities and assets on the consolidated condensed balance sheets .

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

(Unaudited)

Note 3 – Cincinnati Sub-Zero Acquisition

CSZ develops, manufactures and sells patient temperature management systems and product testing equipment. The patient temperature management systems regulate the body temperature of medical patients during and after surgery. The product testing equipment simulates temperature, humidity, altitude and vibration conditions and is customized for use in a wide variety of industrial manufacturing applications.

Results of operations for CSZ are included in the Company’s consolidated condensed financial statements beginning April 1, 2016. CSZ contributed $31,925 in product revenues and a net loss of $1,551 for the nine month periods ended September 30, 2016.

Purchase Price Allocation

The purchase price of $73,593, net of cash acquired of $985, has been allocated to the values of assets acquired and liabilities assumed as of April 1, 2016. The allocation of the purchase price is preliminary. The Company is in the process of obtaining additional information required to finalize the valuation. An appraisal is currently underway by an independent third party valuation firm to assist management in determining the fair value of acquired assets and assumed liabilities, including identifiable intangible assets. The final purchase price allocation may be materially different than the preliminary allocation recorded. The purchase price allocation is expected to be finalized by December 31, 2016. The preliminary allocation as of April 1, 2016 was as follows:


Accounts receivable	$	10,790
Inventory		16,284
Prepaid expenses and other assets		1,143
Property and equipment		12,919
Customer relationships		11,700
Technology		3,200
Trade name		6,370
Goodwill		24,422	^a
Assumed liabilities		(13,235	)

Net assets acquired		73,593
Cash acquired		985

Purchase price	$	74,578

(a)

The preliminary amount recorded to goodwill includes an estimate of consideration owed to the seller for a tax gross up.

The gross contractual amount due of accounts receivable is $11,126 of which $336 is expected to be uncollectible.

The purchase price allocation includes an approximate $4,000 step-up in the underlying net book value of the inventory to its fair value. This inventory was sold to customers and expensed to cost of sales during the three month period ended June 30, 2016.

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

(Unaudited)

Note 3 – Cincinnati Sub-Zero Acquisition – Continued

Supplemental Pro Forma Information

The unaudited pro forma combined historical results including the amounts of CSZ’s revenue and earnings that would have been included in the Company’s consolidated condensed statements of income had the acquisition date been January 1, 2016 or January 1, 2015 are as follows:

	Three Months Ended September 30,		Nine Months Ended September 30,
	2015		2016		2015
Product revenues	$	237,690	$	696,964	$	687,327
Net income	$	25,182	$	50,955	$	65,054
Basic earnings per share	$	0.70	$	1.40	$	1.81
Diluted earnings per share	$	0.69	$	1.39	$	1.79

The pro forma information includes adjustments for the effect of the amortization of intangible assets recognized in the acquisition. This pro forma information is not indicative of future operating results.

Goodwill

We recorded goodwill of approximately $24,422 arising from the acquisition. The acquired goodwill represents intangible assets that do not qualify for separate recognition. It is estimated that all of the goodwill recognized will be deductible for income tax purposes.

Intangible Assets

In conjunction with the acquisition, intangible assets of $21,270 were recorded. The Company’s estimate of the fair value of these assets at the time of the acquisition is preliminary and will be determined with the assistance of an independent third-party valuation firm. As part of the estimated valuation, an estimated useful life for the assets was determined.

Intangible assets, net consisted of the following:

	September 30, 2016
	Gross Value		Accumulated Amortization		Net Value		Useful Life
Customer relationships	$	11,700	$	390	$	11,310	15 yrs
Technology		3,200		260		2,940	5 -7 yrs
Trade name		6,370		—		6,370	Indefinite
Total	$	21,270	$	650	$	20,620

Amortization expense of $327 and $650 for the three and nine months ended September 30, 2016 was recorded as follows:

Three Months Ended
September 30, 2016

Nine Months Ended
September 30, 2016

Product revenues

197

390

Selling, general and administrative expense

130

260

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

(Unaudited)

Note 3 – Cincinnati Sub-Zero Acquisition – Continued

Amortization expense for the prospective five years is estimated to be as follows:

October 1, 2016 through December 31, 2016	$	325
2017	$	1,300
2018	$	1,300
2019	$	1,300
2020	$	1,300
2021	$	1,135

Property, Plant & Equipment

Property and equipment consist of the following:

Asset category	Useful life	Amount
Land	Indefinite	$	1,630
Buildings	20 yrs		6,024
Machinery and equipment	5-7 yrs		3,718
Computer hardware and software	3-5 yrs		586
Assets under construction			961

		$	12,919

Note 4 – Earnings per Share

Basic earnings per share are computed by dividing net income by the weighted average number of shares of stock outstanding during the period. The Company’s diluted earnings per share give effect to all potential Common Stock outstanding during a period that do not have an anti-dilutive impact to the calculation. In computing the diluted earnings per share, the treasury stock method is used in determining the number of shares assumed to be issued from the exercise of Common Stock equivalents.

The following summarizes the Common Stock included in the basic and diluted shares, as disclosed on the face of the consolidated condensed statements of income:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2016		2015		2016		2015
Weighted average number of shares for calculation of basic EPS		36,477,044		36,110,360		36,425,626		35,951,430
Stock options under equity incentive plans		117,537		371,351		132,737		438,612
Weighted average number of shares for calculation of diluted EPS		36,594,581		36,481,711		36,558,363		36,390,042

The accompanying table represents Common Stock issuable upon the exercise of certain stock options that have been excluded from the diluted earnings calculation because the effect of their inclusion would be anti-dilutive.

	Three Months Ended September 30,				Nine Months Ended September 30,
	2016		2015		2016		2015
Stock options outstanding for equity incentive plans		1,455,534		5,534		1,455,534		5,534

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

(Unaudited)

Note 5 – Segment Reporting

Segment information is used by management for making strategic operating decisions for the Company. As discussed in Note 3, Gentherm acquired CSZ on April 1, 2016. The acquisition enhances key elements of our business strategy by expanding the breadth of products derived from core thermal technologies and the markets in which they are applied, such as medical equipment and environmental chamber testing.

Management evaluates the performance of the Company’s segments based primarily on operating income or loss.

The Company’s reportable segments are as follows:

●

Automotive – this segment represents the design, development, manufacturing and sales of automotive seat comfort systems, specialized automotive cable systems and certain automotive and non-automotive thermal convenience products.

•

Industrial – the combined operating results of Gentherm Global Power Technologies (“GPT”), CSZ and Gentherm’s advanced research and development division. Advanced research and development includes efforts focused on improving the efficiency of thermoelectric technologies and advanced heating wire technology as well as other applications. The segment includes government sponsored research projects.

●

Reconciling Items – include corporate selling, general and administrative costs and acquisition transaction costs.

The tables below present segment information about the reported product revenues, depreciation and amortization and operating income (loss) of the Company for three and nine month periods ended September 30, 2016 and 2015. With the exception of goodwill, asset information by segment is not reported since the Company does not manage assets at a segment level. As of September 30, 2016, goodwill assigned to our Automotive and Industrial segments were $22,362 and $30,573, respectively. As of September 30, 2015, goodwill assigned to our Automotive and Industrial segments were $22,218 and $6,305, respectively.

Three Months Ended September 30,	Automotive		Industrial			Reconciling Items			Consolidated Total

2016:
Product revenues	$	212,566	$	20,059		$	—		$	232,625
Depreciation and amortization		8,631		989			557			10,177
Operating income (loss)		54,408		(4,899	)		(22,094	)		27,415
2015:
Product revenues	$	202,734	$	21,084		$	—		$	223,818
Depreciation and amortization		6,956		450			394			7,800
Operating income (loss)		42,123		3,871			(8,545	)		37,449

Nine Months Ended September 30,	Automotive		Industrial			Reconciling Items			Consolidated Total

2016:
Product revenues	$	634,642	$	46,417		$	—		$	681,059
Depreciation and amortization		23,566		2,578			1,580			27,724
Operating income (loss)		133,271		(14,628	)		(38,990	)		79,653
2015:
Product revenues	$	603,131	$	41,037		$	—		$	644,168
Depreciation and amortization		20,157		1,343			1,623			23,123
Operating income (loss)		124,875		959			(34,638	)		91,196

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

(Unaudited)

Note 5 – Segment Reporting – Continued

Total product revenues information by geographic area is as follows:

	Three Months Ended September 30,
	2016				2015
United States	$	117,815	51	%	$	99,833	45	%
China		21,573	9	%		24,092	11	%
Germany		17,670	8	%		18,449	8	%
South Korea		16,295	7	%		18,271	8	%
Japan		10,532	4	%		10,965	5	%
Canada		9,440	4	%		7,353	3	%
Czech Republic		9,302	4	%		7,522	3	%
United Kingdom		6,824	3	%		6,199	3	%
Mexico		5,288	2	%		12,441	6	%
Other		17,886	8	%		18,693	8	%
Total Non U.S.		114,810	49	%		123,985	55	%
	$	232,625	100	%	$	223,818	100	%

	Nine Months Ended September 30,
	2016				2015
United States	$	332,693	49	%	$	293,904	45	%
China		57,983	9	%		58,452	9	%
South Korea		56,443	8	%		62,347	10	%
Germany		54,261	8	%		56,088	9	%
Japan		32,545	5	%		33,482	5	%
Czech Republic		29,264	4	%		20,757	3	%
Canada		28,513	4	%		18,928	3	%
United Kingdom		20,561	3	%		19,825	3	%
Mexico		16,848	2	%		23,200	4	%
Other		51,948	8	%		57,185	9	%
Total Non U.S.		348,366	51	%		350,264	55	%
	$	681,059	100	%	$	644,168	100	%

Note 6 – Debt

Credit Agreement

On March 17, 2016, the Company, together with certain direct and indirect subsidiaries, executed the Second Amendment to the Credit Agreement (the “Amended Credit Agreement”) with a consortium of lenders and Bank of America, N.A., as administrative agent.

The Amended Credit Agreement eliminated without penalty the U.S. Term and Europe Term Loans and increased the aggregate principal amount available for borrowing under the U.S. Revolving Note from $100,000 to $250,000. New subsidiary borrowers and guarantors were added under the Amended Credit Agreement and related pledge and security agreement. The security agreement grants a security interest in substantially all of the personal property of subsidiaries designated as borrowers to secure their respective obligations under the Amended Credit Agreement, including the stock and membership interests of specified subsidiaries (limited to 66% of the stock in the case of certain non-US subsidiaries). The Amended Credit Agreement restricts the amount of dividend payments the Company can make to shareholders.

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

(Unaudited)

Note 6 – Debt – Continued

The Amended Credit Agreement replaced the Company’s requirement to maintain a minimum Consolidated Fixed Charge Coverage Ratio with a minimum Consolidated Interest Coverage Ratio. The Company must also maintain a maximum Consolidated Leverage Ratio. Definitions for these financial ratios, and a description of modifications made to other covenants to which the Company and its subsidiaries are subject, are included in the Amended Credit Agreement.

Under the Amended Credit Agreement, U.S. Dollar denominated loans bear interest at either a base rate (“Base Rate”) or Eurocurrency rate (“Eurocurrency Rate”), plus a margin (“Applicable Rate”). The Base Rate is equal to the highest of the Federal Funds Rate (0.29% at September 30, 2016) plus 0.50%, Bank of America’s prime rate (3.50% at September 30, 2016), or a one month Eurocurrency rate (0.00% at September 30, 2016) plus 1.00%. The Eurocurrency Rate for loans denominated in U.S. Dollars is equal to the London Interbank Offered Rate (0.53% at September 30, 2016). All loans denominated in a currency other than the U.S. Dollar must be Eurocurrency Rate Loans. Interest is payable quarterly.

The Applicable Rate from the initial period of March 17, 2016 through the fiscal quarter ending September 30, 2016 is 1.50% per annum for Eurocurrency Rate Loans and 0.50% per annum for Base Rate Loans. After the initial period, the Applicable Rate will vary based on the Consolidated Leverage Ratio reported by the Company. As long as the Company is not in default of the terms and conditions of the Amended Credit Agreement, the lowest and highest possible Applicable Rate is 1.25% and 2.00%, respectively, for Eurocurrency Rate Loans and 0.25% and 1.00%, respectively, for Base Rate Loans.

The Company also has two fixed interest rate loans with the German Investment Corporation (“DEG”), a subsidiary of KfW Banking Group, a Germany government-owned development bank:

DEG China Loan

The first DEG loan, a loan we used to fund capital investments in China (the “DEG China Loan”), is subject to semi-annual principal payments beginning March, 2015 and ending September, 2019. Under the terms of the DEG China Loan, the Company must maintain a minimum Debt-to-Equity Ratio, Current Ratio and Debt Service Coverage Ratio, as defined by the DEG China Loan agreement, based on the financial statements of Gentherm’s wholly owned subsidiary, Gentherm Automotive Systems (China) Limited.

DEG Vietnam Loan

The Company’s second fixed interest rate loan agreement with DEG was used to finance the construction and set up of the Vietnam production facility (“DEG Vietnam Loan”). The DEG Vietnam Loan is subject to semi-annual principal payments beginning November, 2017 and ending May, 2023. Under the terms of the DEG Vietnam Loan, the Company must maintain a minimum Current Ratio, Equity Ratio and Enhanced Equity Ratio, as defined by the DEG Vietnam Loan agreement, based on the financial statements of Gentherm’s wholly owned subsidiary, Gentherm Vietnam Co. Ltd.

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

(Unaudited)

Note 6 – Debt – Continued

The following table summarizes the Company’s debt at September 30, 2016 and at December 31, 2015.

	September 30, 2016						December 31, 2015
	Interest Rate			Principal Balance			Principal Balance
Credit Agreement:
U.S. Term Loan				$	—		$	46,875
Europe Term Loan					—			20,369
Revolving Note (U.S. Dollar Denominations)		2.02	%		123,875			12,000
DEG China Loan		4.25	%		2,697			3,497
DEG Vietnam Loan		5.21	%		15,000			15,000
Total debt					141,572			97,741
Current portion					(899	)		(4,909	)
Long-term debt, less current maturities				$	140,673		$	92,832

The scheduled principal maturities of our debt as of September 30, 2016 are as follows:

Year	Revolving Note (U.S. Dollar)		DEG China Note		DEG Vietnam Note		Total
2016	$	—	$	—	$	—	$	—
2017		—		899		1,250		2,149
2018		—		899		2,500		3,399
2019		—		899		2,500		3,399
2020		—		—		2,500		2,500
2021		123,875		—		2,500		126,375
Thereafter		—		—		3,750		3,750
Total	$	123,875	$	2,697	$	15,000	$	141,572

Principal outstanding under the Revolving Note will be due and payable in full on March 17, 2021. As of September 30, 2016, we were in compliance with all terms as outlined in the Amended Credit Agreement, DEG China Loan and DEG Vietnam Loan.

Note 7 – Derivative Financial Instruments

We are exposed to market risk from changes in foreign currency exchange rates, short-term interest rates and price fluctuations of certain material commodities such as copper. Market risks for changes in interest rates relate primarily to our debt obligations under our Amended Credit Agreement. Foreign currency exchange risks are attributable to sales to foreign customers and purchases from foreign suppliers not denominated in the location’s functional currency, foreign plant operations, intercompany indebtedness, intercompany investments and include exposures to the European Euro, Mexican Peso, Canadian Dollar, Hungarian Forint, Macedonian Denar, Ukrainian Hryvnia, Japanese Yen, Chinese Renminbi, Korean Won and Vietnamese Dong.

The Company regularly enters into derivative contracts with the objective of managing its financial and operational exposure arising from these risks by offsetting gains and losses on the underlying exposures with gains and losses on the financial instruments used to hedge them. The maximum length of time over which we hedge our exposure to foreign currency exchange risks is one year. We had foreign currency derivative contracts with a notional value of $29,234 and $0 outstanding as of September 30, 2016 and December 31, 2015, respectively.

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

(Unaudited)

Note 7 – Derivative Financial Instruments – Continued

The maximum length of time over which we hedge our exposure to price fluctuations in material commodities is two years. We had copper commodity swap contracts with a notional value of $1,628 and $4,885 outstanding at September 30, 2016 and December 31, 2015, respectively.

We do not enter into derivative financial instruments for speculative or trading purposes. Our hedging relationships are formally documented at the inception of the hedge, and hedges must be highly effective in offsetting changes to future cash flows on hedged transactions both at the inception of a hedge and on an ongoing basis to be designated for hedge accounting treatment. For derivative contracts which can be classified as a cash flow hedge, the effective portion of the change in the fair value of the derivative is recorded to accumulated other comprehensive loss in the consolidated balance sheet. When the underlying hedge transaction is realized, the gain or loss included in accumulated other comprehensive loss is recorded in earnings in the consolidated statement of income on the same line as the gain or loss on the hedged item attributable to the hedged risk. We record the ineffective portion of foreign currency hedging instruments, if any, to foreign currency gain (loss) in the consolidated statements of income. Though we continuously monitor the hedging program, derivative positions and hedging strategies, foreign currency forward exchange agreements have not always been designated as hedging instruments for accounting purposes.

Information related to the recurring fair value measurement of derivative instruments in our consolidated condensed balance sheet as of September 30, 2016 is as follows:

			Liability Derivatives				Net Liabilities
	Hedge Designation	Fair Value Hierarchy	Balance Sheet Location	Fair Value
Foreign currency derivatives	Cash flow hedge	Level 2	Current liabilities	$	(625	)	$	(625	)
Commodity derivatives	Cash flow hedge	Level 2	Current liabilities	$	(181	)	$	(181	)

Information relating to the effect of derivative instruments on our consolidated condensed statements of income is as follows:

	Location	Three Months Ended September 30, 2016			Three Months Ended September 30, 2015			Nine Months Ended September 30, 2016			Nine Months Ended September 30, 2015
Foreign currency derivatives	Revaluation of derivatives	$	—		$	(2,526	)	$	—		$	3,752
	Cost of sales		(112	)		(694	)		23			(1,014	)
	Selling, general and administrative		—			(235	)		139			(189	)
	Other comprehensive income		(868	)		(460	)		(624	)		(1,237	)
	Foreign currency gain		(41	)		31			108			320
Total foreign currency derivatives		$	(1,021	)	$	(3,884	)	$	(354	)	$	1,632
Currency related interest rate swap	Revaluation of derivatives		—			2,392			—			(4,903	)
Commodity derivatives	Cost of sales	$	(157	)	$	—		$	(510	)	$	—
	Other comprehensive income		139			(373	)		544			(421	)
Total commodity derivatives		$	(18	)	$	(373	)	$	34		$	(421	)

We did not incur any hedge ineffectiveness during the three and nine months ended September 30, 2016 and 2015.

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

(Unaudited)

Note 8 – Fair Value Measurement

The Company bases fair value on a price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. We have adopted a fair value hierarchy that prioritizes observable and unobservable inputs used to measure fair value into three broad levels, which are described below:

Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.

Level 2: Inputs, other than quoted market prices included in Level 1, that are observable either directly or indirectly for the asset or liability.

Level 3: Unobservable inputs that are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.

In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible and also considers counterparty credit risk in its assessment of fair value.

Except for derivative instruments (see Note 7), pension liabilities, pension plan assets and a corporate owned life insurance policy, the Company has no material financial assets and liabilities that are carried at fair value at September 30, 2016 and December 31, 2015. The carrying amounts of financial instruments comprising cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities approximate their fair values due to the relatively short maturity of such instruments. The Company uses an income valuation technique to measure the fair values of its debt instruments by converting amounts of future cash flows to a single present value amount using rates based on current market expectations (Level 2 inputs). The carrying values of the Company’s Amended Credit Agreement indebtedness for the periods ending September 30, 2016 and December 31, 2015, respectively, were not materially different than their estimated fair values because the interest rates on variable rate debt approximated rates currently available to the Company (see Note 6). Discount rates used to measure the fair value of Gentherm’s DEG Vietnam Loan and DEG China Loan are based on quoted swap rates. As of September 30, 2016, the carrying values of the DEG Vietnam Loan and DEG China Loan were $15,000 and $2,697, respectively, as compared to an estimated fair value of $15,500 and $2,800 respectively. As of December 31, 2015, the carrying value of the DEG Vietnam Loan and DEG China Loan were $15,000 and $3,497, respectively, as compared to an estimated fair value of $15,100 and $3,600, respectively.

Certain Company assets are required to be recorded at fair value on a non-recurring basis when events and circumstances indicate that the carrying value may not be recoverable. As of September 30, 2016 and December 31, 2015, the Company did not realize any changes to the fair value of these assets due to the non-occurrence of events or circumstances that could negatively impact their recoverability.

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

(Unaudited)

Note 9 – Reclassifications Out of Accumulated Other Comprehensive Income (Loss)

Reclassification adjustments and other activities impacting accumulated other comprehensive income (loss) during the three months ended September 30, 2016 and September 30, 2015 are as follows:

	Defined Benefit Pension Plans			Foreign Currency Translation Adjustments			Commodity Hedge Derivatives			Foreign Currency Hedge Derivatives				Total
Balance at June 30, 2016	$	(2,060	)	$	(47,645	)	$	26		$	179			$	(49,500	)
Other comprehensive income (loss) before reclassifications		—			2,230			(8	)		(818	)			1,404
Income tax effect of other comprehensive income (loss) before reclassifications		—			(13	)		3			220				210
Amounts reclassified from accumulated other comprehensive income (loss) into net income		—			—			147	^a		(50	)	^a		97
Income taxes reclassified into net income		—			—			(54	)		13				(41	)
Net current period other comprehensive income (loss)		—			2,217			88			(635	)			1,670
Balance at September 30, 2016	$	(2,060	)	$	(45,428	)	$	114		$	(456	)		$	(47,830	)

(a)	The amounts reclassified from accumulated other comprehensive income (loss) are included in cost of sales.

	Defined Benefit Pension Plans			Foreign Currency Translation Adjustments			Commodity Hedge Derivatives			Foreign Currency Hedge Derivatives			Total
Balance at June 30, 2015	$	(2,673	)	$	(37,230	)	$	(48	)	$	(577	)	$	(40,528	)
Other comprehensive income (loss) before reclassifications		—			(4,429	)		(392	)		(873	)		(5,694	)
Income tax effect of other comprehensive income (loss) before reclassifications		—			51			162			237			450
Amounts reclassified from accumulated other comprehensive income (loss) into net income		—			—			19	^a		413	^a		432
Income taxes reclassified into net income		—			—			(7	)		(112	)		(119	)
Net current period other comprehensive income (loss)		—			(4,378	)		(218	)		(335	)		(4,931	)
Balance at September 30, 2015	$	(2,673	)	$	(41,608	)	$	(266	)	$	(912	)	$	(45,459	)

(a)	The amounts reclassified from accumulated other comprehensive income (loss) are included in cost of sales.

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

(Unaudited)

Note 9 – Reclassifications Out of Accumulated Other Comprehensive Income (Loss) – Continued

Reclassification adjustments and other activities impacting accumulated other comprehensive income (loss) during the nine months ended September 30, 2016 and September 30, 2015 are as follows:

	Defined Benefit Pension Plans			Foreign Currency Translation Adjustments			Commodity Hedge Derivatives			Foreign Currency Hedge Derivatives				Total
Balance at December 31, 2015	$	(2,060	)	$	(49,381	)	$	(229	)	$	—			$	(51,670	)
Other comprehensive income (loss) before reclassifications					2,866			94			(117	)			2,843
Income tax effect of other comprehensive income (loss) before reclassifications		—			1,087			(35	)		32				1,084
Amounts reclassified from accumulated other comprehensive income (loss) into net income		—			—			450	^a		(507	)	^a		(57	)
Income taxes reclassified into net income		—			—			(166	)		136				(30	)
Net current period other comprehensive income (loss)		—			3,953			343			(456	)			3,840
Balance at September 30, 2016	$	(2,060	)	$	(45,428	)		114			(456	)			(47,830	)

(a)	The amounts reclassified from accumulated other comprehensive income (loss) are included in cost of sales.

	Defined Benefit Pension Plans			Foreign Currency Translation Adjustments			Commodity Hedge Derivatives				Foreign Currency Hedge Derivatives			Total
Balance at December 31, 2014	$	(2,673	)	$	(23,060	)	$	—			$	(10	)	$	(25,743	)
Other comprehensive income (loss) before reclassifications		—			(19,312	)		(419	)			(1,746	)		(21,477	)
Income tax effect of other comprehensive income (loss) before reclassifications		—			764			162				473			1,399
Amounts reclassified from accumulated other comprehensive income (loss) into net income		—			—			(2	)	^a		509	^a		507
Income taxes reclassified into net income		—			—			(7	)			(138	)		(145	)
Net current period other comprehensive income (loss)		—			(18,548	)		(266	)			(902	)		(19,716	)
Balance at September 30, 2015	$	(2,673	)	$	(41,608	)	$	(266	)		$	(912	)	$	(45,459	)

(a)	The amounts reclassified from accumulated other comprehensive income (loss) are included in cost of sales.

We expect all of the existing gains and losses related to foreign currency and commodity derivatives reported in accumulated other comprehensive income as of September 30, 2016 to be reclassified into earnings during the twelve month period ending December 31, 2016.

ITEM 2.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Forward-Looking Statements

This Report contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements represent our goals, beliefs, plans and expectations about our prospects for the future and other future events, such as our ability to finance sufficient working capital, the amount of availability under our credit facility, our ability to continue to maintain or increase sales and profits of our operations, and the sufficiency of our cash balances and cash generated from operating, investing and financing activities for our future liquidity and capital resource needs. Reference is made in particular to forward-looking statements included in this “Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Such statements may be identified by the use of forward-looking terminology such as “may”, “will”, “expect”, “believe”, “estimate”, “anticipate”, “intend”, “continue”, or similar terms, variations of such terms or the negative of such terms. The forward-looking statements included in this Report are made as of the date hereof or as of the date specified and are based on management’s current expectations and beliefs. Such statements are subject to a number of assumptions, risks, uncertainties and other factors, which are set forth in this Report, under “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2015 and subsequent reports filed with or furnished to the Securities and Exchange Commission, and which could cause actual results to differ materially from that described in the forward looking statements. Except as required by law, we expressly disclaim any obligation or undertaking to update any forward-looking statements to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

The following discussion and analysis should be read in conjunction with, and is qualified in its entirety by, our financial statements and related notes thereto included elsewhere in this Report and in our Annual Report on Form 10-K for the year ended December 31, 2015.

Overview

Gentherm is a global technology and industry leader in the design, development, and manufacturing of innovative thermal management technologies and automotive cable systems. Our products provide solutions for automotive passenger comfort and convenience, battery thermal management, remote power generation, patient temperature management, and other consumer and industrial temperature control needs. Our automotive products can be found on the vehicles of nearly all major automotive manufacturers in North America, Europe and Asia. We operate in locations aligned with our major customers’ product strategies in order to provide locally enhanced design, integration and production capabilities and to identify future thermal technology product opportunities in both automotive and other markets. We concentrate our research on the development of new technologies that will enable new products, improve overall effectiveness of existing products and maximize customer satisfaction. We also focus on developing new design applications from our existing technologies to create new products and market opportunities for thermal comfort solutions.

Our automotive products are sold to automobile and light truck OEMs or their tier one suppliers. Inherent in this market are costs and commitments that are incurred well in advance of the receipt of orders (and resulting revenues) from customers. This is due in part to automotive manufacturers requiring the design, coordination and testing of proposed new components and sub-systems. Revenues from these expenditures are typically not realized for two to three years due to this development cycle.

The Company has two reportable segments for financial reporting purposes: Automotive and Industrial. See Note 5 to our consolidated condensed financial statements for a description of our reportable segments as well as their proportional contribution to the Company’s reported product revenues and operating income. The financial information used by our chief operating decision maker to assess operating performance and allocate resources is based on these reportable segments.

Related to the Reorganization, the Company declared an intercompany dividend, incurred and paid a related withholding tax to Revenue Canada and recorded a tax expense of approximately $6,300,000, during the first quarter of 2016. Later during the quarter, a further intercompany dividend was declared and paid resulting in an additional $1,300,000 withholding tax being paid and expensed and the Company changed its assessment of the potential for further dividends and accrued and expensed, but did not pay, an estimated final withholding tax amount totaling $2,000,000. This estimate is expected to cover the amount of all future intercompany dividends needed to distribute the remaining earnings of the subsidiary to its parent in conjunction with the final liquidation of the subsidiary.

In addition to the $9,600,000 in combine d withholding taxes, the Reorganization will require the Company to make a one-time income tax payment of approximately $32,000,000. The one-time income tax payment was accrued during the first quarter of 2016; however, the Company also recorded an offset ting deferred charge for approximately the same amount because the one-time income tax payment will result in tax deductions against income taxes in future periods. Therefore, the income tax payment did not have a material impact on the Company’s earnings during the first quarter of 2016 and is not expected to in any future fiscal quarter. The income tax payment will be paid during 2017.

On April 1, 2016, we acquired all of the equity of privately-held Cincinnati Sub-Zero Products, LLC (“CSZ”) and related assets in an all-cash transaction. CSZ manufactures both high quality patient temperature management systems for the health care industry and custom testing equipment used by a wide range of industrial manufacturing companies for product testing. CSZ’s world headquarters and manufacturing operations are located in Cincinnati, Ohio. See Note 3 to the consolidated condensed financial statements included herein for additional information regarding CSZ.

Third Quarter 2016 Compared with Third Quarter 2015

Product Revenues . Our product revenues for the three months ended September 30, 2016 (“Third Quarter 2016”) were $232,625,000 compared with product revenues of $223,818,000 for the three months ended September 30, 2015 (“Third Quarter 2015”), an increase of $8,807,000, or 4%. This increase was attributable to the acquisition of CSZ, which we acquired on April 1, 2016, and continued growth in our automotive products, partially offset by lower product revenues from Gentherm Global Power Technologies (“GPT”). Revenues for CSZ during the Third Quarter 2016 were $14,947,000. Our automotive product revenues were higher during the Third Quarter 2016 including higher sales for Climate Controlled Seats (“CCS”) which increased by $1,944,000, or 2% to $101,028,000, higher sales for Automotive Seat Heaters which increased by $7,077,000, or 10% to $75,442,000 and Steering Wheel Heaters which increased by $1,977,000, or 18% to $12,914,000. Product revenues from GPT totaled $5,112,000 which represented a decrease of $15,972,000, or 76%. This decrease partly reflects continued softness in the demand for GPT’s products in North America, which continues to be unfavorably impacted by the market weakness in the oil industry that has carried over to and reduced capital investments being made by GPT’s principal customers that build and operate natural gas pipelines and related natural gas exploration and production companies. During prior quarters, this weakness had been offset by higher sales of products that are sold into geographical markets outside of GPT’s home market of North America. However, these are typically larger custom products which are more impacted by the timing of shipments which favor some quarterly periods over others. Fewer of these custom systems were shipped during Third Quarter 2016.

Our product revenues were not significantly impacted by fluctuations in foreign currency exchange rates when compared to Third Quarter 2015.

Cost of Sales. Cost of sales increased to $155,931,000 during Third Quarter 2016 from $148,892,000 during Third Quarter 2015. This increase of $7,039,000, or 5%, was due to increased sales volume, including the new product revenues from CSZ and higher overhead for our new production facilities in Vietnam and Macedonia. The gross margin percentage was 33.0% during Third Quarter 2016 representing a slight decrease from 33.5% during Third Quarter 2015. The lower gross margin was due to the lower GPT revenue, which has a higher gross margin percentage, offset partially by a favorable foreign currency impact on production expenses.

Net Research and Development Expenses. Net research and development expenses were $19,745,000 during Third Quarter 2016 compared to $14,934,000 in Third Quarter 2015, an increase of $4,811,000, or 32%. This increase was primarily driven by higher costs for additional resources, including personnel, focused on application engineering for new production programs of existing products, development of new products and a program to develop the next generation of seat comfort products. New product development includes automotive cooled storage devices, automotive interior thermal management devices, medical thermal management devices, battery thermal management devices, battery management systems, advanced automotive electronics solutions and other potential products.

Many of these new products have begun to reach the more cost intensive phases that typically occur after we receive firm customer orders or later as we ramp up our manufacturing operations specific to these products. Important examples include battery thermal management and a new automotive electronic control module, which will begin shipping at the end of 2017 and in early 2019, respectively. During Third Quarter 2016 our expenses associated with battery thermal management totaled $1,000,000 and were $500,000 for the electronic module. We estimate that these two products will add over $50,000,000 in annual revenue by the time they reach their full run rate in 2019 based on current awarded programs and are likely to grow rapidly in later periods. The growth in the battery thermal management product is expected to mirror an expected rapid growth in 48-volt mild hybrid automotive drive trains for which it is designed whereas the growth in the electronic control module product is anticipated to be driven by market share penetration due to an important design innovation that we believe gives us an important competitive advantage.

The CSZ acquisition also increased our net research and development expenses by $755,000. These increases were partially offset by research and development reimbursement totaling $1,236,000 during Third Quarter 2016 and $3,276,000 during Third

Quarter 2015. We expect that our research and development reimbursem ents as well as some related expenses will decrease during the year due to the expiration of our research program with the U.S. Department of Energy.

We classify development and prototype costs and related reimbursements as net research and development expenses. This is consistent with accounting standards applied in the automotive industry. Depreciation costs for tooling are included in cost of sales.

Acquisition Transaction Expenses. During Third Quarter 2016, we incurred $22,000 in fees and expenses associated with the acquisition of CSZ which was completed on April 1, 2016. We did not incur any such costs during Third Quarter 2015.

Selling, General and Administrative Expenses. Selling, general and administrative expenses increased to $29,512,000, which included $4,670,000 in selling, general and administrative expenses for CSZ, during Third Quarter 2016 from $22,543,000 during Third Quarter 2015. Excluding the CSZ expenses, selling, general and administrative expenses increased by $2,299,000, or 10%. This amount includes costs associated with two important business software application implementation projects totaling $1,324,000 and a smaller benefit from stock appreciation rights (“SAR’s”) granted to our employees of $1,036,000.

During 2016 we launched projects to implement a new human resource management system (“HRMS”) and a new product lifecycle management application (“PLM”). These new business applications are essential to support our future growth in both core product lines and for new products currently in development. Our current solutions have become outdated due to our past growth. Expenses for these projects during Third Quarter 2016 include both ongoing subscription expenses of $589,000 and implementation costs of $735,000. The quarterly implementation costs will increase over the next several quarterly periods but are expected to be completed by the end of 2017 at which time we will have a much improved capacity to accommodate additional growth at a more efficient cost.

Our management incentive program includes various forms of equity compensation including stock options, restricted stock and SARs. Stock options and restricted stock are accounted for using the equity method and are valued at the grant date fair value and amortized over the respective service period of the employee beneficiary. SARs are accounted for using the liability method since they are settled in cash which requires mark-to-market adjustments based on the current trading price of our Common Stock. Since the trading price of our Common Stock decreased during Third Quarter 2016 and Third Quarter 2015. We recorded SAR-related compensation benefits totaling $238,000 for Third Quarter 2016 as compared with a benefit of $1,274,000 during Third Quarter 2015, a change that increased our total selling, general and administrative expense by $1,036,000 quarter to quarter.

Income Tax Expense. We recorded an income tax expense of $6,018,000 during Third Quarter 2016 representing an effective tax rate of 23% on earnings before income tax of $26,241,000. During Third Quarter 2015, we recorded an income tax expense of $9,798,000 representing an effective tax rate of 26% on earnings before income tax of $37,463,000. This reduction was due to lower average tax rates on our foreign income. The effective tax rates for Third Quarter 2016 and Third Quarter 2015 were lower than the U.S. Federal rate of 34% primarily due to the impact of lower statutory rates for our subsidiaries operating in foreign jurisdictions.

Year to Date 2016 Compared with Year to Date 2015

Product Revenues . Our product revenues for the nine months ended September 30, 2016 (“YTD 2016”) were $681,059,000 compared with product revenues of $644,168,000 for the nine months ended September 30, 2015 (“YTD 2015”), an increase of $36,891,000, or 6%. This increase was attributable to the acquisition of CSZ, which we acquired on April 1, 2016, and continued growth in our automotive seating products, partially offset by lower product revenues from GPT. Revenues for CSZ during YTD 2016 were $31,925,000. Our automotive product revenues were higher during YTD 2016 including higher sales for CCS which increased by $7,462,000, or 2% to $307,993,000, higher sales for Automotive Seat Heaters which increased by $15,417,000, or 8% to $220,522,000 and Steering Wheel Heaters which increased by $6,137,000, or 20% to $37,103,000. Product revenues from GPT totaled $14,492,000 which represented a decrease of $26,550,000, or 65%. This decrease partly reflects continued softness in the demand for GPT’s products in North America, which continues to be unfavorably impacted by the market weakness in the oil industry that has carried over to and reduced capital investments being made by GPT’s principal customers that build and operate natural gas pipelines and related natural gas exploration and production companies. During prior quarters, this weakness had been offset by higher sales of products that are sold into geographical markets outside of GPT’s home market of North America. However, these are typically larger custom products which are more impacted by the timing of shipments which favor some quarterly periods over others. Fewer of these custom systems were shipped during YTD 2016.

A portion of our product revenues come from sales to customers in foreign countries, much of which are denominated in European Euros but also include sales in Chinese Yuan, South Korean Won, Canadian Dollar and Japanese Yen. Since the end of YTD 2015, the average market value of these currencies declined against the U.S. Dollar, our reporting currency. Consequently, our foreign currency denominated revenue has resulted in lower U.S. Dollar reported product revenues. Had the YTD 2016 average exchange rates for these currencies been the same as YTD 2015 average exchange rates, our product revenues would have been $3,300,000 higher than that reported for YTD 2016.

Cost of Sales. Cost of sales increased to $464,628,000 during YTD 2016 from $436,967,0 00 during YTD 2015. This increase of $27,661,000, or 6%, was due to increased sales volume, including the new product revenues from CSZ, higher overhead for our new production facility in Vietnam and a one-time $3,973,000 expense from the purchase accounti ng effect of inventory for the CSZ acquisition. The gross margin percentage was 31.8% during YTD 2016. This amount would have been 32.3% without the impact of the one-time purchase accounting impact for CSZ which is 0.1% higher than the gross margin perc entage of 32.2% during YTD 2015. This higher gross margin percentage is due to higher gross margins for CSZ and favorable foreign currency impact on production expenses in MXN and UAH and partially offset by lower revenue for GPT which has a higher gross margin percent. Our manufacturing plants are located in the Ukraine, Macedonia, Mexico, Canada, China and Vietnam. As a result, our production labor costs are incurred in the local currency of each of those countries. During YTD 2016, MXN and UAH decrea sed in value as compared to the U.S. Dollar resulting in lower production costs.

Net Research and Development Expenses. Net research and development expenses were $54,552,000 during YTD 2016 compared to $44,459,000 in YTD 2015, an increase of $10,093,000, or 23%. This increase was primarily driven by higher costs for additional resources, including personnel, focused on application engineering for new production programs of existing products, development of new products and a program to develop the next generation of seat comfort products. New product development includes automotive cooled storage devices, automotive interior thermal management devices, medical thermal management devices, battery thermal management devices, battery management systems, advanced automotive electronics solutions and other potential products. The CSZ acquisition also increased our net research and development expenses by $1,144,000. These increases were partially offset by research and development reimbursement totaling $4,450,000 during YTD 2016 and $6,882,000 during YTD 2015. We expect that our research and development reimbursements as well as some related expenses will decrease during the year due to the expiration of our research program with the U.S. Department of Energy.

Acquisition Transaction Expenses. During YTD 2016, we incurred $693,000 in fees and expenses associated with the acquisition of CSZ which was completed on April 1, 2016. We did not incur any such costs during YTD 2015.

Selling, General and Administrative Expenses. Selling, general and administrative expenses increased to $81,533,000, which included $10,218,000 in selling, general and administrative expenses for CSZ, during YTD 2016 from $71,546,000 during YTD 2015. Excluding the CSZ expenses, selling, general and administrative expenses decreased by $231,000, or less than 1%. This small decrease resulted from lower management incentive expenses mostly being offset by higher operating expenses from the new HRMS and PLM business software implementation projects totaling $1,918,000 and from higher wages and benefits costs resulting from new employee hiring, merit increases and administrative costs associated with the new facilities in Vietnam and Macedonia.

Since the trading price of our Common Stock decreased during YTD 2016 but increased during YTD 2015, we recorded SAR-related compensation benefit totaling $1,713,000 for YTD 2016 as compared with an expense of $5,224,000 during YTD 2015, a change that reduced our total selling, general and administrative expense by $6,937,000 YTD to YTD.

Income Tax Expense. We recorded an income tax expense of $27,646,000 during YTD 2016 which included the one-time withholding tax payment totaling $6,300,000 and other adjustments totaling $3,300,000 related to the Reorganization. Excluding this one-time expense and other adjustments, our income tax expense would have been $18,046,000 representing an effective tax rate of 23% on earnings before income tax of $78,208,000. During YTD 2015, we recorded an income tax expense of $22,891,000 representing an effective tax rate of 25% on earnings before income tax of $89,870,000. This reduction was due to lower average tax rates on our foreign income. The effective tax rates for YTD 2016, excluding the one-time expense and other adjustments related to the reorganization, and YTD 2015 were lower than the U.S. Federal rate of 34% primarily due to the impact of lower statutory rates for our subsidiaries operating in foreign jurisdictions.

Liquidity and Capital Resources

The Company has funded its financial needs primarily through cash flows from operating activities and equity and debt financings. Based on its current operating plan, management believes cash and cash equivalents at September 30, 2016, together with cash flows from operating activities, are sufficient to meet operating and capital expenditure needs, and to service debt, for the foreseeable future. However, if cash flows from operations decline, we may need to obtain alternative sources of capital and reduce or delay capital expenditures, acquisitions and investments, all of which could impede the implementation of our business strategy and adversely affect our results of operations and financial condition. In addition, it is likely that we will need to complete one or more equity or debt financings if we consummate any significant acquisitions. There can be no assurance that such capital will be available at all or on reasonable terms, which could adversely affect our future operations and business strategy.

On March 17, 2016 we completed a refinancing of our existing credit agreement. See Note 6 to the consolidated condensed financial statements for additional information about the amendment made to the credit agreement. Given our current cash reserves l evels and strategic business plans, a portion of the outstanding revolving loan balances could be repaid prior to the due date of March 17, 2021.

The following table represents our cash and cash equivalents and short-term investments which are available for our business operations:

	Nine Months Ended September 30,			Twelve Months Ended December 31,
	2016			2015
	(in Thousands)
Cash and cash equivalents at beginning of period	$	144,479		$	85,700
Cash from operating activities		71,011			104,712
Cash used in investing activities		(124,290	)		(62,728	)
Cash from financing activities		41,547			24,426
Foreign currency effect on cash and cash equivalents		66			(7,631	)
Cash and cash equivalents at end of period	$	132,813		$	144,479

We manage our cash, cash equivalents and short-term investments in order to fund operating requirements and preserve liquidity to take advantage of future business opportunities. Cash and cash equivalents decreased by $11,666,000 during YTD 2016. Cash provided by operating activities during YTD 2016 was $71,011,000 and was attributable to net income of $50,562,000, plus non-cash adjustments. Non-cash adjustments included depreciation and amortization of $27,724,000 and stock compensation of $6,856,000. Partially offsetting these positive cash flows from operating activities was a deferred income tax benefit of $1,825 ,000 and a change in net operating assets and liabilities of $13,025,000, including working capital items.

As of September 30, 2016, working capital was $262,893,000 as compared to $276,825,000 at December 31, 2015, a decrease of $13,932,000, or 5%. Aside from the impact of cash and cash equivalents, this decrease was primarily related to increases in accounts payable and accrued liabilities and decreases in prepaid expenses and other assets totaling $11,699,000, $50,532,000 and $3,941,000, respectively. The accrued income tax liability of approximately $32,000,000 described above is included within accrued liabilities. These decreases in working capital were partially offset by increases in accounts receivable and inventory and a decrease in the current maturities of our long-term debt of $36,355,000, $23,021,000 and $4,010,000, respectively. Accounts receivable primarily increased as a result of increases in product revenues, timing differences between when sales during Third Quarter 2016 were realized compared with sales realized during the fourth quarter of 2015, as well as one-time delays associated with the billing entities involved in the North American reorganization. See Note 1 to the consolidated condensed financial statement for more information about the reorganization of our North America business. CSZ’s contribution to working capital at September 30, 2016 was $14,308,000. Working capital was also affected by changes in currency exchange rates.

Cash used in investing activities was $124,290,000 during YTD 2016, reflecting the acquisition of CSZ and purchases of property and equipment and related to expansion of production capacity, including construction of new production facilities in Mexico, Vietnam and Macedonia, and replacement of existing equipment. See Note 3 to the consolidated condensed financial statement included herein for information regarding the acquisition of CSZ.

Cash provided by financing activities was $41,547,000 during YTD 2016, reflecting proceeds borrowed against our amended credit agreement totaling $75,000,000. These proceeds were offset by payments of principal on the Revolving Note and DEG China Loan totaling $32,368,000 in aggregate. As of September 30, 2016, the total availability under the Revolving Note was $125,341,000. Cash also was paid for cancellations of restricted stock awards and the payment of financing costs associated with the amendment made to our credit agreement totaling $1,196,000 and $650,000, respectively. See Note 6 to the consolidated condensed financial statements included herein for information the amended credit agreement, DEG China Loan and DEG Vietnam Loan.

ITEM 3.

QUANTITATIVE AND QUALITATI VE DISCLOSURES ABOUT MARKET RISK

Our exposure to market risk for changes in interest rates relates primarily to our debt obligations and foreign currency contracts. We have in the past, and may in the future, place our investments in bank certificates of deposits, debt instruments of the U. S. government, and in high-quality corporate issuers.

We are exposed to market risk from changes in foreign currency exchange rates, short-term interest rates and price fluctuations of certain material commodities such as copper. Market risks for changes in interest rates relate primarily to our debt obligations under our Credit Agreement. Foreign currency exchange risks are attributable to sales to foreign customers and purchases from foreign suppliers not denominated in the location’s functional currency, foreign plant operations, intercompany indebtedness, intercompany investments and include exposures to the European Euro, Mexican Peso, Canadian Dollar, Hungarian Forint, Macedonian Denar, Ukrainian Hryvnia, Japanese Yen, Chinese Renminbi, Korean Won and Vietnamese Dong.

The Company regularly enters into derivative contracts with the objective of managing our financial and operational exposure arising from these risks by offsetting gains and losses on the underlying exposures with gains and losses on the financial instruments used to hedge them. The maximum length of time over which we hedge our exposure to foreign currency exchange risks is one year. We had foreign currency derivative contracts with a notional value of $29,234,000 and $0 outstanding as of September 30, 2016 and December 31, 2015, respectively.

The maximum length of time over which we hedge our exposure to price fluctuations in material commodities is two years. We had copper commodity swap contracts with a notional value of $1,628,000 and $4,885,000 outstanding at September 30, 2016 and December 31, 2015, respectively.

The Company uses an income approach to value derivative instruments, analyzing quoted market prices to calculate the forward values and then discounts such forward values to the present value using benchmark rates at commonly quoted intervals for the instrument’s full term. Information related to the fair values of all derivative instruments in our consolidated condensed balance sheet as of September 30, 2016 is set forth in Note 7 to the consolidated condensed financial statements included herein.

Interest Rate Sensitivity

The table presents principal cash flows and related weighted average interest rates by expected maturity dates for each of the Company’s debt obligations. The information is presented in U.S. dollar equivalents, which is the Company’s reporting currency. The instruments actual cash flows are denominated in US dollars ($USD) or European Euros (€EUR), as indicated in parentheses.

September 30, 2016

	Expected Maturity Date
	2016		2017			2018			2019			2020			Thereafter			Total			Fair Value
	(In thousands except rate information)
Liabilities
Long Term Debt:
Fixed Rate (€EUR)	$	—	$	899		$	899		$	899		$	—			—		$	2,697		$	2,800
Fixed Interest Rate				4.25	%		4.25	%		4.25	%								4.25	%
Variable Rate ($USD)	$	—		—			—			—			—			123,875		$	123,875		$	123,875
Average Interest Rate																2.02	%		2.02	%
Fixed Rate ($USD)	$	—	$	1,250		$	2,500		$	2,500		$	2,500		$	6,250		$	15,000		$	15,500
Fixed Interest Rate				5.21	%		5.21	%		5.21	%		5.21	%		5.21	%		5.21	%

Exchange Rate Sensitivity

The table below provides information about the Company’s foreign currency forward exchange rate agreements that are sensitive to changes in foreign currency exchange rates. The table presents the notional amounts and weighted average exchange rates by expected (contractual) maturity dates for each type of foreign currency forward exchange agreement. These notional amounts generally are used to calculate the contractual payments to be exchanged under the contract.

September 30, 2016

	Expected Maturity or Transaction Date
Anticipated Transactions And Related Derivatives	2016		2017		2018		2019		2020		Thereafter		Total		Fair Value
	(In thousands except rate information)
$US functional currency
Forward Exchange Agreements:
(Receive MXN/Pay USD$)
Total Contract Amount ($)	$	8,316	$	5,584		—		—		—		—	$	13,900	$	(557	)
Average Contract Rate		18.40		19.34										18.78
(Receive CAD/Pay USD$)
Total Contract Amount ($)	$	—	$	15,334		—		—		—		—	$	15,334	$	(68	)
Average Contract Rate				1.30										1.30

Commodity Price Sensitivity

The table below provides information about the Company’s futures contracts that are sensitive to changes in commodity prices, specifically copper prices. For the futures contracts the table presents the notional amounts in metric tons (MT), the weighted average contract prices, and the total dollar contract amount by expected maturity dates. Contract amounts are used to calculate the contractual payments and quantity of copper to be exchanged under the futures contracts.

September 30, 2016

	Carrying Amount			Fair Value
On Balance Sheet Commodity Position and Related Derivatives (in thousands)	$	(181	)	$	(181	)

	Expected Maturity
	2016			Fair Value
Related Derivatives
Futures Contracts (Long):
Contract Volumes (metric tons)		300
Weighted Average Price (per metric ton)	$	5,428
Contract Amount (in thousands) ($)	$	1,628		$	(181	)

ITEM 4.

CONTROLS AND PROCEDURES

(a) Evaluation of Disclosure Controls and Procedures

As of the end of the period covered by this quarterly report, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of September 30, 2016, our disclosure controls and procedures were effective to ensure the information required to be disclosed by us in reports that we file or submit under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized, and reported within the time periods prescribed by the Securities and Exchange Commission, and that such information is accumulated and communicated to management, including the Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

(b) Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting that occurred during the quarter ended September 30, 2016 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II OTHER INFORMATION

ITEM 1.

LEGAL PROCEEDINGS

We are subject to litigation from time to time in the ordinary course of business, however there is no current material pending litigation to which we are a party and no material legal proceeding was terminated, settled or otherwise resolved during the nine months ended September 30, 2016.

ITEM 1A.

RISK FACTORS

In June, 2016, the United Kingdom (U.K.) voted to exit the European Union (“Brexit”) in a referendum vote, which caused significant volatility in global stock markets and currency exchange rate fluctuations that resulted in the strengthening of the U.S. dollar against foreign currencies in which we conduct business. Volatility in exchange rates is currently expected to continue in the short term as the U.K. negotiates its exit from the European Union. The announcement of Brexit and the subsequent negotiations for the withdrawal of the U.K. from the European Union may also create global economic uncertainty, which may impact, among other things, global light vehicle production. Gentherm does not generate revenues denominated in the British Pound. Therefore, recent depreciation in the currency as a result of Brexit is not expected to have a significant impact on the Company’s net sales.

There were no other material changes in our risk factors previously disclosed in Part I, Item 1A “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2015. You should carefully consider the risks and uncertainties described therein.

ITEM 6.

EXHIBITS

Exhibits to this Report are as follows:

Incorporated by Reference

Exhibit
Number

Exhibit Description

Filed Herewith

Form

Period Ending

Exhibit /
Appendix Number

Filing Date

31.1

Section 302 Certification – CEO

31.2

Section 302 Certification – CFO

32.1

Section 906 Certification – CEO

32.2

Section 906 Certification – CFO

101.INS

XBRL Instance Document.

101.SCH

XBRL Taxonomy Extension Schema Document.

101.CAL

XBRL Taxonomy Extension Calculation Linkbase Document.

101.DEF

XBRL Taxonomy Extension Definition Linkbase Document.

101.LAB

XBRL Taxonomy Extension Label Linkbase Document.

101.PRE

XBRL Taxonomy Extension Presentation Linkbase Document.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Gentherm Incorporated

/s/ D ANIEL R. C OKER

Daniel R. Coker

Chief Executive Officer

(Duly Authorized Officer)

Date: October 28, 2016

/s/ B ARRY G. S TEELE

Barry G. Steele

Chief Financial Officer

(Principal Financial Officer and Principal Accounting Officer)

Date: October 28, 2016

Gentherm (NASDAQ:THRM)
Historical Stock Chart
From Mar 2024 to Apr 2024